Table of Contents Author Guidelines Submit a Manuscript
Journal of Immunology Research
Volume 2015, Article ID 860106, 11 pages
http://dx.doi.org/10.1155/2015/860106
Research Article

Spontaneous Intestinal Tumorigenesis in Mice Requires Altered T Cell Development with IL-17A

Department of Immunobiology, Yale University School of Medicine, New Haven, CT 06520, USA

Received 17 December 2014; Revised 6 May 2015; Accepted 6 May 2015

Academic Editor: David E. Gilham

Copyright © 2015 Wook-Jin Chae and Alfred L. M. Bothwell. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. A. Mantovani, P. Allavena, A. Sica, and F. Balkwill, “Cancer-related inflammation,” Nature, vol. 454, no. 7203, pp. 436–444, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Y. Rudensky, “Regulatory T cells and Foxp3,” Immunological Reviews, vol. 241, no. 1, pp. 260–268, 2011. View at Publisher · View at Google Scholar
  3. S. K. Lathrop, N. A. Santacruz, D. Pham, J. Luo, and C.-S. Hsieh, “Antigen-specific peripheral shaping of the natural regulatory T cell population,” Journal of Experimental Medicine, vol. 205, no. 13, pp. 3105–3117, 2008. View at Publisher · View at Google Scholar · View at Scopus
  4. L. J. Thompson, A. C. Valladao, and S. F. Ziegler, “Cutting edge: de novo induction of functional Foxp3+ regulatory CD4 T cells in response to tissue-restricted self antigen,” Journal of Immunology, vol. 186, no. 8, pp. 4551–4555, 2011. View at Publisher · View at Google Scholar · View at Scopus
  5. S. Sakaguchi, T. Yamaguchi, T. Nomura, and M. Ono, “Regulatory T cells and immune tolerance,” Cell, vol. 133, no. 5, pp. 775–787, 2008. View at Publisher · View at Google Scholar · View at Scopus
  6. Y. Wang, M. A. Su, and Y. Y. Wan, “An essential role of the transcription factor GATA-3 for the function of regulatory T cells,” Immunity, vol. 35, no. 3, pp. 337–348, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. E. A. Wohlfert, J. R. Grainger, N. Bouladoux et al., “GATA3 controls Foxp3+ regulatory T cell fate during inflammation in mice,” The Journal of Clinical Investigation, vol. 121, no. 11, pp. 4503–4515, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. W. Zou, “Regulatory T cells, tumour immunity and immunotherapy,” Nature Reviews Immunology, vol. 6, no. 4, pp. 295–307, 2006. View at Publisher · View at Google Scholar
  9. W. L. Byrne, K. H. G. Mills, J. A. Lederer, and G. C. O'Sullivan, “Targeting regulatory T cells in cancer,” Cancer Research, vol. 71, no. 22, pp. 6915–6920, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. P. Salama, M. Phillips, F. Grieu et al., “Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer,” Journal of Clinical Oncology, vol. 27, no. 2, pp. 186–192, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. F. Pagès, A. Berger, M. Camus et al., “Effector memory T cells, early metastasis, and survival in colorectal cancer,” The New England Journal of Medicine, vol. 353, no. 25, pp. 2654–2666, 2005. View at Publisher · View at Google Scholar
  12. D. M. Frey, R. A. Droeser, C. T. Viehl et al., “High frequency of tumor-infiltrating FOXP3+ regulatory T cells predicts improved survival in mismatch repair-proficient colorectal cancer patients,” International Journal of Cancer, vol. 126, no. 11, pp. 2635–2643, 2010. View at Publisher · View at Google Scholar · View at Scopus
  13. S. Ladoire, F. Martin, and F. Ghiringhelli, “Prognostic role of FOXP3+ regulatory T cells infiltrating human carcinomas: the paradox of colorectal cancer,” Cancer Immunology, Immunotherapy, vol. 60, no. 7, pp. 909–918, 2011. View at Publisher · View at Google Scholar · View at Scopus
  14. S. E. Erdman, J. J. Sohn, V. P. Rao et al., “CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice,” Cancer Research, vol. 65, no. 10, pp. 3998–4004, 2005. View at Publisher · View at Google Scholar · View at Scopus
  15. K. W. Kinzler and B. Vogelstein, “Lessons from hereditary colorectal cancer,” Cell, vol. 87, no. 2, pp. 159–170, 1996. View at Publisher · View at Google Scholar · View at Scopus
  16. I. Näthke, “Cytoskeleton out of the cupboard: colon cancer and cytoskeletal changes induced by loss of APC,” Nature Reviews Cancer, vol. 6, no. 12, pp. 967–974, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. W.-J. Chae, T. F. Gibson, D. Zelterman, L. Hao, O. Henegariu, and A. L. M. Bothwell, “Ablation of IL-17A abrogates progression of spontaneous intestinal tumorigenesis,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 12, pp. 5540–5544, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. H. Shibata, K. Toyama, H. Shioya et al., “Rapid colorectal adenoma formation initiated by conditional targeting of the Apc gene,” Science, vol. 278, no. 5335, pp. 120–133, 1997. View at Publisher · View at Google Scholar · View at Scopus
  19. B. Weigmann, I. Tubbe, D. Seidel, A. Nicolaev, C. Becker, and M. F. Neurath, “Isolation and subsequent analysis of murine lamina propria mononuclear cells from colonic tissue,” Nature Protocols, vol. 2, no. 10, pp. 2307–2311, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. K. J. Livak and T. D. Schmittgen, “Analysis of relative gene expression data using real-time quantitative PCR and the 2-ΔΔCT method,” Methods, vol. 25, no. 4, pp. 402–408, 2001. View at Publisher · View at Google Scholar · View at Scopus
  21. P. L. Coletta, A. M. Muller, E. A. Jones et al., “Lymphodepletion in the ApcMin/+ mouse model of intestinal tumorigenesis,” Blood, vol. 103, pp. 1050–1058, 2004. View at Publisher · View at Google Scholar
  22. W. Zou and N. P. Restifo, “TH17 cells in tumour immunity and immunotherapy,” Nature Reviews Immunology, vol. 10, no. 4, pp. 248–256, 2010. View at Publisher · View at Google Scholar
  23. J. Shoemaker, M. Saraiva, and A. O'Garra, “GATA-3 directly remodels the IL-10 locus independently of IL-4 in CD4+ T cells,” The Journal of Immunology, vol. 176, no. 6, pp. 3470–3479, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Akimova, U. H. Beier, L. Wang, M. H. Levine, and W. W. Hancock, “Helios expression is a marker of T cell activation and proliferation,” PLoS ONE, vol. 6, no. 8, Article ID e24226, 2011. View at Publisher · View at Google Scholar · View at Scopus
  25. R. A. Gottschalk, E. Corse, and J. P. Allison, “Expression of Helios in peripherally induced Foxp3+ regulatory T cells,” Journal of Immunology, vol. 188, no. 3, pp. 976–980, 2012. View at Publisher · View at Google Scholar · View at Scopus
  26. A. M. Thornton, P. E. Korty, D. Q. Tran et al., “Expression of Helios, an Ikaros transcription factor family member, differentiates thymic-derived from peripherally induced Foxp3+ T regulatory cells,” Journal of Immunology, vol. 184, no. 7, pp. 3433–3441, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. S. Wu, K.-J. Rhee, E. Albesiano et al., “A human colonic commensal promotes colon tumorigenesis via activation of T helper type 17 T cell responses,” Nature Medicine, vol. 15, no. 9, pp. 1016–1022, 2009. View at Publisher · View at Google Scholar · View at Scopus
  28. I. Kryczek, K. Wu, E. Zhao et al., “IL-17+ regulatory T cells in the microenvironments of chronic inflammation and cancer,” The Journal of Immunology, vol. 186, no. 7, pp. 4388–4395, 2011. View at Publisher · View at Google Scholar
  29. J. L. Round and S. K. Mazmanian, “Inducible Foxp3+ regulatory T-cell development by a commensal bacterium of the intestinal microbiota,” Proceedings of the National Academy of Sciences of the United States of America, vol. 107, no. 27, pp. 12204–12209, 2010. View at Publisher · View at Google Scholar · View at Scopus
  30. M. J. Barnes and F. Powrie, “Regulatory T cells reinforce intestinal homeostasis,” Immunity, vol. 31, no. 3, pp. 401–411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  31. J. van Loosdregt, V. Fleskens, M. Tiemessen et al., “Canonical Wnt signaling negatively modulates regulatory T cell function,” Immunity, vol. 39, no. 2, pp. 298–310, 2013. View at Publisher · View at Google Scholar · View at Scopus
  32. E. Gounaris, N. R. Blatner, K. Dennis et al., “T-regulatory cells shift from a protective anti-inflammatory to a cancer-promoting proinflammatory phenotype in polyposis,” Cancer Research, vol. 69, no. 13, pp. 5490–5497, 2009. View at Publisher · View at Google Scholar · View at Scopus
  33. I. I. Ivanov, R. D. L. Frutos, N. Manel et al., “Specific microbiota direct the differentiation of IL-17-producing T-helper cells in the mucosa of the small intestine,” Cell Host and Microbe, vol. 4, no. 4, pp. 337–349, 2008. View at Publisher · View at Google Scholar · View at Scopus
  34. S. Le Gouvello, S. Bastuji-Garin, N. Aloulou et al., “High prevalence of Foxp3 and IL17 in MMR-proficient colorectal carcinomas,” Gut, vol. 57, no. 6, pp. 772–779, 2008. View at Publisher · View at Google Scholar · View at Scopus
  35. G. Betts, E. Jones, S. Junaid et al., “Suppression of tumour-specific CD4+ T cells by regulatory T cells is associated with progression of human colorectal cancer,” Gut, vol. 61, pp. 1163–1171, 2012. View at Publisher · View at Google Scholar